Fig. 1From: PIK3CA mutation status, progression and survival in advanced HR + /HER2- breast cancer: a meta-analysis of published clinical trialsPreferred Reporting Items for Systematic Reviews and Meta-Analysis guidelines diagram for electronic searchBack to article page